The International Society for Vaccines (ISV) is excited to announce that the Annual Congress will be held in historic Québec City, Canada, at the Québec City Convention Centre on September 18-20, 2022.
The 2022 Congress is co-chaired by Joon Haeng Rhee, Manon Cox, and Gary Kobinger.
Preliminary Congress info to enthuse you for the upcoming Congress:
- The ISV Annual Congress is the world’s largest non-commercial scientific conference for basic and clinical researchers interested in vaccines and the underlying sciences, with broad coverage of topics related to vaccines and immunotherapies ranging from basic research through manufacturing and clinical trials for human and veterinary vaccines encompassing infectious diseases and cancer.
- The conference provides a platform to exchange ideas through lively discussions led by session chairs and through vibrant interactive poster sessions among the attendees.
- Gender balance of session chairs and speakers as well as balance of the career stage of speakers is strongly supported.
- A further attribute is inclusion of a high percentage of speakers selected from submitted abstracts, in addition to the invited keynote speakers.
- Special efforts are made to help trainees advance their careers with a career development panel discussion, feedback of poster presentations by senior scientists, and ISV’s mentoring program.
- The ‘Bright Sparks in Vaccinology’ session is where trainees compete for a prestigious award in a friendly, high-energy competitive forum.
- The ISV Annual General Meeting is held as part of the Annual Congress to determine key ISV policies and elect members of the ISV Board. Participation in the ISV is an excellent way to increase your scientific network and visibility.
- The Congress includes representation from global and regional vaccine groups such as the Korean Vaccine Society (KVS), the Japanese Society of Vaccines (JSV) and the ISV China branch.
- Several awards will be available to support delegates from low- and middle-income countries and junior scientists in vaccine sciences, with further updates to be announced.